A Prospective Safety Trial of Atorvastatin Treatment to Assess Rebleeding after Spontaneous Intracerebral Hemorrhage: A Serial MRI Investigation

AIM: This study was designed to determine any rebleeding after atorvastatin treatment following spontaneous intracerebral hemorrhage (ICH) in a prospective safety trial. PATIENTS: Atorvastatin (80 mg/day) therapy was initiated in 6 patients with primary ICH with admission Glasgow Coma Score (GCS) &g...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Austin J Cerebrovasc Dis Stroke
Hlavní autoři: Knight, RA, Nagaraja, TN, Li, L, Jiang, Q, Tundo, K, Chopp, M, Seyfried, DM
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5436718/
https://ncbi.nlm.nih.gov/pubmed/28529979
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky